Shengxian Xu

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University

发表论文 14 篇 · 总被引 221 次 · h-index 6

代表论文

• Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma (2022 · Frontiers in Genetics · 被引 106)
• Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer (2022 · Frontiers in Oncology · 被引 32)
• Pan-cancer analysis reveals the prognostic and immunotherapeutic value of cytoskeleton-associated protein 2-like (2023 · Scientific Reports · 被引 20)
• CircGNG4 Promotes the Progression of Prostate Cancer by Sponging miR-223 to Enhance EYA3/c-myc Expression (2021 · Frontiers in Cell and Developmental Biology · 被引 17)
• Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs (2022 · Frontiers in Immunology · 被引 15)
• CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy (2023 · Frontiers in Oncology · 被引 14)